{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:18:58Z","timestamp":1789143538538,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.canlet.2023.216368","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T11:37:32Z","timestamp":1693309052000},"page":"216368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway"],"prefix":"10.1016","volume":"577","author":[{"given":"Chuntao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar-Ming","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-9130","authenticated-orcid":false,"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0288-6306","authenticated-orcid":false,"given":"Zhixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216368_bib1","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2023.216368_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215945","article-title":"Neoantigen discovery and applications in glioblastoma: an immunotherapy perspective","volume":"550","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2021.12.014","article-title":"Drug repositioning: using psychotropic drugs for the treatment of glioma","volume":"527","author":"You","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tibs.2016.02.004","article-title":"DSS1\/Sem1, a multifunctional and intrinsically disordered protein","volume":"41","author":"Kragelund","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2023.216368_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4161\/nucl.1.1.10424","article-title":"Sem1: a versatile \"molecular glue\"?","volume":"1","author":"Faza","year":"2010","journal-title":"Nucleus (Calcutta)"},{"key":"10.1016\/j.canlet.2023.216368_bib7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.onc.1209153","article-title":"DSS1 is required for the stability of BRCA2","volume":"25","author":"Li","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2023.216368_bib8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41374-021-00613-6","article-title":"Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas","volume":"101","author":"Gondo","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.canlet.2023.216368_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/carcin\/bgs279","article-title":"Identification of the deleted in split hand\/split foot 1 protein as a novel biomarker for human cervical cancer","volume":"34","author":"Ma","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2023.216368_bib10","first-page":"1075","article-title":"Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer, Cell","volume":"27","author":"Tamilzhalagan","year":"2015","journal-title":"Signals"},{"key":"10.1016\/j.canlet.2023.216368_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1186\/1471-2407-13-562","article-title":"Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival","volume":"13","author":"Rezano","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2023.216368_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9090873","article-title":"Withanolide C inhibits proliferation of breast cancer cells via oxidative stress-mediated apoptosis and DNA damage","volume":"9","author":"Yu","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.canlet.2023.216368_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13287-020-1563-8","article-title":"Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN\/AKT pathway","volume":"11","author":"Wen","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.canlet.2023.216368_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13105-019-00716-1","article-title":"Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1\/9","volume":"76","author":"Wang","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2023.216368_bib15","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.7150\/thno.74281","article-title":"Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216368_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10565-013-9248-z","article-title":"Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma","volume":"29","author":"Vlachostergios","year":"2013","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.canlet.2023.216368_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.onc.1208225","article-title":"Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)","volume":"24","author":"Yin","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2023.216368_bib18","first-page":"50","article-title":"Differential effects of the proteasome inhibitor NPI-0052 against glioma cells, transl","volume":"3","author":"Vlashi","year":"2010","journal-title":"Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2023.216368_bib20","article-title":"HMOX1 promotes lung adenocarcinoma metastasis by affecting macrophages and mitochondrion complexes","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215861","article-title":"HULC targets the IGF1R-PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance","volume":"548","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215660","article-title":"PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma","volume":"536","author":"Chen","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside, Semin","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Cancer Biol"},{"key":"10.1016\/j.canlet.2023.216368_bib24","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/neuonc\/noac064","article-title":"PI3K\/AKT\/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications","volume":"24","author":"Mohamed","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/17590914211001218","article-title":"Knockdown of annexin-A1 inhibits growth, migration and invasion of glioma cells by suppressing the PI3K\/Akt signaling pathway","volume":"13","author":"Wei","year":"2021","journal-title":"ASN Neuro"},{"key":"10.1016\/j.canlet.2023.216368_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12890-022-02303-5","article-title":"FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K\/AKT\/NF-\u03baB pathway","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.canlet.2023.216368_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","article-title":"NF-kB in development and progression of human cancer","volume":"446","author":"Dolcet","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2023.216368_bib28","series-title":"Oleuropein Counteracts Both the Proliferation and Migration of Intra- and Extragonadal Seminoma Cells","first-page":"14","author":"Bossio","year":"2022"},{"key":"10.1016\/j.canlet.2023.216368_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/genes13101892","article-title":"RNA modification-related genetic variants in genomic loci associated with bone mineral density and fracture","volume":"13","author":"Han","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.canlet.2023.216368_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.canlet.2021.11.014","article-title":"Jolkinolide B sensitizes bladder cancer to mTOR inhibitors via dual inhibition of Akt signaling and autophagy","volume":"526","author":"Sang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib31","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1172\/JCI133310","article-title":"Everolimus improves the efficacy of dasatinib in PDGFR\u03b1-driven glioma","volume":"130","author":"Miklja","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216368_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-008-9741-z","article-title":"A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)","volume":"92","author":"Kreisl","year":"2009","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215799","article-title":"Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma","volume":"543","author":"Shimizu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216368_bib35","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S1470-2045(17)30679-4","article-title":"Dabrafenib plus trametinib in patients with previously untreated BRAF(V600E)-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial","volume":"18","author":"Planchard","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer","volume":"36","author":"Subbiah","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1470-2045(21)00578-7","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600E)-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial","volume":"23","author":"Wen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216368_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","article-title":"Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy","volume":"29","author":"Inoue","year":"2014","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.canlet.2023.216368_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11302-021-09775-w","article-title":"Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth","volume":"17","author":"Lopes","year":"2021","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.canlet.2023.216368_bib40","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1021\/acsami.7b18135","article-title":"Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme","volume":"10","author":"Ye","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216368_bib41","series-title":"Glioma Stem Cell Signature Predicts the Prognosis and the Response to Tumor Treating Fields Treatment","author":"Chen","year":"2022"},{"key":"10.1016\/j.canlet.2023.216368_bib42","doi-asserted-by":"crossref","first-page":"D1311","DOI":"10.1093\/nar\/gkaa840","article-title":"Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics","volume":"49","author":"Ghoussaini","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216368_bib43","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216368_bib44","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216368_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2023.216368_bib46","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216368_bib47","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2023.216368_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215811","article-title":"Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma","volume":"544","author":"Biswas","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215903","article-title":"Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma","volume":"549","author":"Zhu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216368_bib50","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","article-title":"ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells","volume":"156","author":"Yang","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2023.216368_bib51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.canlet.2023.216368_bib52","series-title":"Prognosis and Personalized Treatment Prediction in TP53-Mutant Hepatocellular Carcinoma: an in Silico Strategy towards Precision Oncology","first-page":"22","author":"Yang","year":"2021"},{"key":"10.1016\/j.canlet.2023.216368_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2023.216368_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105924","article-title":"A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma","volume":"148","author":"Chen","year":"2022","journal-title":"Comput. Biol. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:11:55Z","timestamp":1759594315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523003191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":54,"alternative-id":["S0304383523003191"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216368","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216368"}}